Chromium Research & Evidence

SupplementScience.ai Editorial Team·Evidence-Based Supplement Research

Published Mar 11, 2026

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Moderate

Chromium supplementation evidence is mixed but leans positive for blood sugar management. A comprehensive meta-analysis by Balk et al. (2007, 41 RCTs) found modest improvements in glycemic control among type 2 diabetes patients, with the strongest effects at doses of 200-1,000mcg chromium picolinate. The Anderson et al. (1997) China trial remains the most cited positive study, showing significant HbA1c reduction with 1,000mcg/day. However, the ADA does not recommend routine chromium supplementation for diabetes due to inconsistency across trials. For weight loss, a Cochrane review found effects too small to be clinically meaningful.

Evidence by Condition

Condition	Studied Dose	Evidence
Type 2 diabetes support	200-1,000mcg chromium picolinate daily	Moderate
Insulin sensitivity	200-500mcg daily	Moderate
Weight management	200-400mcg daily	Emerging
Carbohydrate cravings	600-1,000mcg daily	Emerging

Full Chromium Guide

References

Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG (2007). Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. DOI PubMed
Anderson RA, Cheng N, Bryden NA, et al. (1997). Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. DOI PubMed
Tian H, Guo X, Wang X, et al. (2013). Chromium picolinate supplementation for overweight or obese adults. Cochrane Database of Systematic Reviews. DOI PubMed